Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for prevention of periprocedural myocardial injury during PCI
IRCT20111206008307N33Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in coronary arteriosclerosis comparing Colchicine plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoints: Change in CK-MB level and Change in cardiac troponin I level. Started Sep 2018; status: completed.
02
Drugs
colchicine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20111206008307N33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111206008307N33.